
Paragon 28 announced the pricing of its initial public offering of 7,812,500 shares of its common stock at $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting discounts and commissions and estimated offering expenses.
The company’s common stock began trading on the New York Stock Exchange on October 15, 2021, under the ticker symbol FNA. The offering is expected to close on October 19, 2021.
BofA Securities and Piper Sandler are acting as joint lead book-running managers for the offering. Canaccord Genuity is acting as a lead manager. JMP Securities and Needham & Company are acting as co-managers.
Source: Paragon 28
Paragon 28 announced the pricing of its initial public offering of 7,812,500 shares of its common stock at $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting discounts and commissions and estimated offering expenses.
The company's common stock began trading on the New York Stock Exchange on October 15,...
Paragon 28 announced the pricing of its initial public offering of 7,812,500 shares of its common stock at $16.00 per share, for total gross proceeds of $125.0 million, before deducting underwriting discounts and commissions and estimated offering expenses.
The company’s common stock began trading on the New York Stock Exchange on October 15, 2021, under the ticker symbol FNA. The offering is expected to close on October 19, 2021.
BofA Securities and Piper Sandler are acting as joint lead book-running managers for the offering. Canaccord Genuity is acting as a lead manager. JMP Securities and Needham & Company are acting as co-managers.
Source: Paragon 28
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.





